Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus
β Scribed by Kozora, Elizabeth ;Ellison, Misoo C. ;West, Sterling
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 118 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Objective
To examine the reliability and validity of the proposed American College of Rheumatology (ACR) neuropsychological battery for patients with systemic lupus erythematosus (SLE).
Methods
Thirtyβone SLE patients with a history of neuropsychiatric symptoms (NPSLE), 22 SLE patients without a history of neuropsychiatric symptoms (nonβNPSLE), and 25 healthy controls completed measures of cognition at baseline and after 1 month. The 1βhour proposed ACRβSLE battery was compared with a 4βhour comprehensive battery (CB).
Results
Seven of 12 measures from the ACRβSLE battery were lower in SLE patients compared with controls. Overall agreement between impairment on the ACRβSLE battery and the CB was 90%. This was established using previously defined impairment on the CB and 4 of 12 scores impaired on the ACRβSLE battery. Almost perfect agreement between the 2 batteries was found for nonβNPSLE patients and healthy controls (95β96%) and moderate agreement was reported for NPSLE patients (81%). Intraclass correlation coefficients for ACRβSLE tests ranged from 0.40 to 0.90, indicating adequate reliability.
Conclusion
Reliability and validity of the ACRβSLE battery was established in this study. Agreement regarding classification for impairment was almost perfect for nonβNPSLE and moderate for the NPSLE patients. The ACR battery is well designed for general classification of cognitive impairment in SLE. However, comprehensive testing may be useful in identifying specific deficits in NPSLE.
π SIMILAR VOLUMES
## Abstract ## Objective Improved standards for the evaluation of therapeutic interventions in systemic lupus erythematosus (SLE) are needed. The purpose of this study by a committee of the American College of Rheumatology was to define clinically meaningful improvement, no change, or worsening in